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Abstract
 
Mast cells are found in connective and mucosal tissues throughout the body. Their activation
via immunoglobulin E (IgE)–antigen interactions is promoted by T helper cell type 2 (Th2) cy-
tokines and leads to the sequelae of allergic disease. We now report a mechanism by which Th2
cytokines can regulate mast cell survival. Specifically, we find that interleukin (IL)-4 and IL-10
induce apoptosis in IL-3–dependent bone marrow–derived mast cells and peritoneal mast cells.
This process required 6 d of costimulation with IL-3, IL-4, and IL-10, and expression of signal
transducer and activator of transcription 6 (Stat6). Apoptosis was coupled with decreased ex-
 
pression of 
 
bcl-x
 
L
 
 and 
 
bcl-2
 
. While this process occurred independent of the Fas pathway, cul-
 
ture in IL-3
 
1
 
IL-4
 
1
 
IL-10 greatly sensitized mast cells to Fas-mediated death. Additionally, we
found that IgE cross-linkage or stimulation with stem cell factor enhanced the apoptotic abili-
ties of IL-4 and IL-10. Finally, IL-3–independent mastocytomas and mast cell lines were resis-
 
tant to apoptosis induced by IL-3
 
1
 
IL-4
 
1
 
IL-10. These data offer evidence of Th2 cyto-
kine–mediated homeostasis whereby these cytokines both elicit and limit allergic responses.
Dysregulation of this pathway may play a role in allergic disease and mast cell tumor survival.
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Introduction
 
Mast cells are inflammatory effector cells that are concen-
trated in connective and mucosal tissues. Their role in al-
lergic diseases such as asthma, allergic rhinitis, food aller-
gies, atopic dermatitis, and systemic anaphylaxis has been
well-documented (1, 2). When mast cells are activated
through cross-linkage of their high-affinity Fc
 
e
 
RI recep-
tors, they release preformed and newly synthesized media-
tors including histamine, serine proteases, arachidonic acid
metabolites, and cytokines. The result is an inflammatory
response that includes vasodilation, bronchial and gas-
trointestinal smooth muscle contraction, and recruitment
of leukocytes. There are three key components that con-
tribute to mast cell–mediated allergic disease: the presence
of environmental antigens, production of antigen-specific
IgE, and mast cell activation and hyperplasia. The latter
two of these components can be affected by Th2 cytokines,
including IL-4 and IL-10. For example, IL-4 acts as a pro-
liferative factor for mast cells and promotes Ig class switch-
ing in B cells from IgM to IgE, whereas IL-10 induces both
mast cell proliferation and differentiation (3–7).
We have recently reported activities of IL-4 and IL-10
that argue for a homeostatic role of these cytokines in mast
cell function. Using mouse bone marrow–derived mast
cells (BMMCs),
 
1
 
 we demonstrated that IL-4 and IL-10 de-
crease expression and signaling of Fc
 
e
 
RI and Kit (8, 9).
These data led us to postulate that Th2 cytokines may
function in a homeostatic fashion. The proinflammatory
roles of these Th2 cytokines (e.g., IgE production, short-
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term mast cell proliferation, and survival) may be balanced
by negative regulatory effects (decreased expression and
function of proinflammatory receptors). Supporting this
homeostatic hypothesis is the observation that negative reg-
ulatory events occur only after several days of cytokine ex-
posure, thus allowing for both pro- and antiinflammatory
phases of the immune response.
This study reinforces the homeostatic role of IL-4 and
IL-10. We show that combined stimulation with IL-4 and
IL-10 induces apoptosis of IL-3–dependent BMMCs or of
purified peritoneal mast cells. As with the regulation of IgE
and Kit receptors, the apoptotic activity of IL-4 and IL-10
was not apparent until several days of culture. Our results
demonstrate a role for IL-4 and IL-10 in the regulation of
mast cell survival, and elucidate some of the mechanisms of
this observation. Dysregulation of this homeostasis could
underlie the pathophysiology of allergic disease.
 
Materials and Methods
 
Cells and Reagents.
 
BMMCs were derived from 6–12-wk-old
C57BL/6, C57BL/6 
 
3
 
 129, C57BL/6 
 
lpr
 
, C57BL/6 
 
gld
 
 (all from
Taconic Farms), or BL/6 
 
3
 
 129 signal transducer and activator of
transcription (Stat)6-deficient mice (donated by James Ihle, St.
Jude Research Hospital, Memphis, TN) by culturing unseparated
bone marrow cells at 5 
 
3 
 
10
 
5
 
/ml in complete RPMI supple-
mented with 20% WEHI-3 conditioned medium (cRPMI/
WEHI) for 3 wk. Mast cell phenotype was confirmed by flow cy-
tometric analysis (FACScan™; Becton Dickinson, hereafter re-
ferred to as FACS
 
®
 
) using antibodies specific for Kit, CD13, IgE,
or Fc
 
g
 
RII/RIII, and by histochemical staining (data not shown).
At the time of use, BMMC cultures were 
 
.
 
99% mast cells.
BMMCs were maintained in cRPMI/WEHI for up to 6 mo, but
were generally used for experiments within 2 mo of reaching day
21 in culture. Peritoneal mast cells were isolated by peritoneal la-
vage, using ice-cold Hank’s balanced salt solution lacking Mg
 
2
 
1
 
or Ca
 
2
 
1 
 
and phenol red (Biofluids). Peritoneal lavage exudates
were centrifuged at 150 
 
g
 
 for 5 min. Pellets were gently drained,
and resuspended in 72.5% Percoll (Amersham Pharmacia Bio-
tech). Samples were centrifuged for 7 min at 300 
 
g
 
. Pellets were
collected and cultured in complete RPMI at 37
 
8
 
C for 1 h to re-
move any residual macrophages. Nonadherent cells were re-
moved and plated in the indicated cytokines. Mast cells com-
prised 85–90% of the resultant cell population, as determined by
Wright-Giemsa staining.
 
Cytokines and Antibodies.
 
Murine IL-3, IL-4, and IL-10 were
purchased from BioSource International. PE-coupled streptavidin
and rat anti–mouse TNF-
 
a
 
, FITC-labeled annexin V, unlabeled
mouse IgE, and biotinylated antibodies specific for Fas, FasL, and
hamster IgG were purchased from BD PharMingen. Rat anti–
mouse IgE and goat F(ab
 
9
 
)
 
2
 
 anti–rat IgG (H
 
1
 
L) were purchased
from Southern Biotechnology Associates, Inc. Antibodies to bcl-2
and bcl-x
 
L
 
 were obtained from Santa Cruz Biotechnology, Inc.,
and Transduction Laboratories, respectively.
 
Analysis of Apoptosis.
 
For analysis of mast cell apoptosis, cells
were cultured at 
 
z
 
3.0 
 
3
 
 10
 
5
 
 cells/ml in IL-3 (5 ng/ml), or in IL-3
with IL-4 (10 ng/ml) and/or IL-10 (10 ng/ml) for 6 d. On day 4,
cells were fed by replacing half of the medium and cytokines. On
day 6, cells were fixed overnight in a solution of 150 
 
m
 
l 70% eth-
anol, 25 
 
m
 
l 1
 
3
 
 PBS, and 25 
 
m
 
l fetal bovine serum and then
stained in a solution of 94% 1
 
3
 
 PBS, 50 
 
m
 
g/ml propidium iodide
 
(PI), 100 
 
m
 
g/ml RNase A, and 10
 
2
 
4
 
 mM EDTA. Fluorescent in-
tensities were determined by FACS
 
®
 
 analysis. Annexin V staining
was performed with the TACS Annexin V-FITC kit from Trevi-
gen, according to the manufacturer’s specifications. For cell
counts, BMMCs were prepared as described above and then ana-
lyzed by FACS
 
®
 
 for 20-s periods of time over which total num-
bers of viable cells were recorded.
 
Fas and FasL Expression and Function.
 
At day 3 of culture in
IL-3 alone or in IL-3 plus IL-4 and/or IL-10, BMMCs were in-
cubated with 0.3 
 
m
 
l 2.4G2 rat anti–mouse Fc
 
g
 
RII/RIII ascites
per 100 
 
m
 
l for 10 min at 4
 
8
 
C, followed by 10 
 
m
 
g/ml of biotin-
ylated anti-Fas or anti-FasL in 1
 
3
 
 PBS, 3% fetal bovine serum,
and 0.1% sodium azide (FACS buffer) for 30 min. After being
washed in FACS buffer, cells were incubated for 30 min with 10
 
m
 
g/ml of PE-coupled streptavidin and analyzed by FACScan™.
To investigate the role of Fas signaling on BMMCs, cells were
cultured and analyzed as described above for PI staining, except
that 20 
 
m
 
g/ml of anti-Fas Ab was added on day 3 of culture.
 
bcl-2 and bcl-x
 
L
 
 mRNA Analysis.
 
RNA was harvested from
BMMCs at day 6 with Trizol (GIBCO BRL), and an RNase
Protection assay (RPA) was performed using a kit, probe, and
protocol from the RiboQuant System (BD PharMingen). Quan-
titation of mRNA expression was determined using a Phosphor-
imaging 445si System (Molecular Dynamics).
 
bcl-2 and bcl-x
 
L
 
 Protein Analysis.
 
Whole cell lysates were pre-
pared in 20 mM Tris-HCl, pH 7.5, 135 mM NaCl, 1 mM
EDTA, 1 mM EGTA, 1 mM sodium vanadate, 0.05 mM NaF,
0.5% NP-40, and 1% Triton X-100. 20 
 
m
 
g of cleared lysates was
resolved on a 12% SDS-PAGE acrylamide gel and transferred to
nitrocellulose using semidry blot transfer. The blot was blocked
for 1 h in TBST buffer (25 mM Tris, pH 7.8, 125 mM NaCl,
and 0.25% Tween 20) containing 5% nonfat milk and then incu-
bated in mouse anti–
 
bcl-x
 
L
 
 antibody (1:500 dilution; Upstate Bio-
technology) overnight at 4
 
8
 
C in TBST/5% nonfat milk. The blot
was washed in TBST buffer, and specific reactive proteins were
detected using enhanced chemiluminescence (Amersham Phar-
macia Biotech). The blot was then stripped of antibody by incu-
bation of the blot in 2% SDS and 62.5 mM Tris buffer, pH 6.7, at
50
 
8
 
C for 30 min, rinsed in TBST buffer, reblocked in TBST/5%
nonfat milk, and probed for anti–
 
bcl-2
 
 antibody (1:1,000; Santa
Cruz Biotechnology, Inc.) by the same procedure.
 
IgE Cross-Linkage Studies.
 
BMMCs were cultured in IL-3 (5
ng/ml) for 3 d before activation. We have found this necessary
for maximal cytokine production (our unpublished observations).
Cells were then incubated with IgE (10 
 
m
 
g/ml) for 45 min at 4
 
8
 
C
in cRPMI
 
1
 
IL-3 (5 ng/ml), washed, and incubated with rat anti–
mouse IgE (5 
 
m
 
g/ml) for 30 min at 37
 
8
 
C, followed by goat
F(ab
 
9
 
)
 
2
 
 anti–rat IgG (H
 
1
 
L, 5 
 
m
 
g/ml) for 5 h at 37
 
8
 
C. A subset of
cells was stained for expression of TNF-
 
a
 
 production to confirm
cytokine production. After 5 h of activation, IL-4 and IL-10 were
added to cultures, and BMMCs were further incubated for 6 d,
with feeding on day 4, and assessed for apoptosis by PI staining.
 
Statistical Analysis.
 
Analyses of variance were performed at 
 
a
 
 
 
5
 
0.05 using Statmost software (DataMost).
 
Results
 
IL-4 and IL-10 Induce Apoptosis in BMMCs.
 
To inves-
tigate the role of IL-4 and IL-10 in mast cell apoptosis,
BMMCs were cultured in IL-3 alone or in IL-3 with IL-4
and/or IL-10. The length of culture depended on the tech-
nique for assessing apoptosis. For detecting the early stages 
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of apoptosis, cells were incubated for 3 d, followed by
staining with FITC-coupled annexin V. Annexin V binds
phosphatidylserine found on the outer leaflet of cells un-
dergoing “membrane flipping,” an event characteristic of
early apoptosis (10). As shown in Fig. 1 A, BMMCs cul-
tured in IL-3
 
1
 
IL-4
 
1
 
IL-10 demonstrated increased an-
nexin V staining compared with cells cultured in IL-3
alone. BMMCs cultured in IL-3
 
1
 
IL-4 or in IL-3
 
1
 
IL-10
showed no change in annexin V binding (data not shown),
indicating that dual stimulation with IL-4 and IL-10 was
required to induce apoptosis.
A later stage of apoptosis is characterized by the system-
atic fragmentation of the cell’s DNA by its own nucleases.
Decreases in DNA content can be determined by PI stain-
ing. For this procedure, cells were cultured for 6 d in IL-3
alone or in IL-3 with IL-4 and/or IL-10 before analysis.
BMMCs cultured in IL-3 alone showed very little subdip-
loid DNA content, whereas those cultured in IL-3
 
1
 
IL-
4
 
1
 
IL-10 showed an increase in subdiploid DNA (Fig. 1
B). Fig. 1 C shows a summary of PI staining results ob-
tained from multiple experiments. Neither IL-4 nor IL-10
alone was able to induce apoptosis in IL-3–treated BMMCs
after 6 d of culture. Percentages of apoptotic BMMCs were
11.7 (
 
6 
 
0.6%) for IL-3
 
1
 
IL-4–treated cells and 9.8 (
 
6
 
0.8%) for IL-3
 
1
 
IL-10–treated cells compared with 7.6 (
 
6
 
0.4%) for cells treated in IL-3 alone. Only culture of IL-3–
treated BMMCs with IL-4 and IL-10 was able to induce
significant apoptosis, seen in 30.1% (
 
6 
 
2.4%) of cells after
Figure 1. IL-4 and IL-10 induce apoptosis in BMMCs. (A) BMMCs were cultured
in IL-3 alone or in IL-31IL-41IL-10 for 3 d, stained with FITC–annexin V, and an-
alyzed by flow cytometry. Cells cultured in IL-31IL-41IL-10 had a relative mean flu-
orescent intensity of 49.0 compared with 20.3 for cells incubated in IL-3 alone. (B)
BMMCs were cultured in either IL-3 alone or in IL-31IL-41IL-10 for 6 d, stained
with PI, and analyzed by flow cytometry. Cells with less than G1/G0 DNA content fall
within the M1 region and are considered apoptotic. (C) BMMC apoptosis expressed
in percentages as determined by PI staining. Results are means and standard errors
from 38 experiments using 9 individual BMMC populations. BMMCs were cultured
for 6 d with the combinations of cytokines shown in the bar graph. *P , 0.05. (D)
Time course of apoptosis as determined by PI staining. *P , 0.05. (E) Counts of viable
BMMCs cultured in IL-3 alone, IL-31SCF, or IL-31IL-41IL-10 over a 6-d period.
Cell numbers were determined by running samples through FACS® over 20-s inter-
vals. Data shown are for one BMMC population and are representative of three experi-
ments using five different BMMC populations.1096 Th2 Cytokines Induce Mast Cell Apoptosis
6 d. Apoptosis appeared to continue with time in culture,
with an increased percentage of apoptotic cells over a 14-d
time course (Fig. 1 D). We also found this effect to be dose
responsive, with little or no apoptosis observed when the
concentration of IL-4 or IL-10 was decreased ,5 ng/ml
(data not shown).
In Fig. 1 E, the number of viable BMMCs is shown for
cells cultured in IL-3 alone or in IL-31IL-41IL-10 over
6 d. The number of viable BMMCs cultured in IL-31IL-
41IL10 increased sharply and peaked at day 4 before di-
minishing on day 5. By day 6, the number of cells treated
with IL-31IL-41IL-10 was slightly less than the baseline
number of IL-3–cultured BMMCs. These data argue that
while costimulation with IL-4 and IL-10 induces mast cell
proliferation, this mitogenic activity declines with time in
culture, resulting in no net increase in cell numbers com-
pared with cells cultured in IL-3 alone.
Importantly, similar cultures containing IL-3 plus stem
cell factor (SCF) consistently demonstrated equal or greater
rates of proliferation than cultures receiving IL-31IL-
41IL-10, yet demonstrated very low rates of apoptosis
(Fig. 2, and data not shown). These data, coupled with the
fact that our cultures were maintained at a low cell density
and fed every 4 d, argue against exhaustion of medium
components as an explanation for the observed apoptosis.
IL-4 and IL-10 Induce Apoptosis in BMMCs Cultured in
IL-3 with SCF. Since SCF is likely to be present under
conditions of a Th2 response and is a potent mast cell sur-
vival factor, we considered its effect on IL-4– and IL-10–
induced BMMC apoptosis. As shown in Fig. 2, BMMCs
cultured in IL-31SCF were 4.9% apoptotic. In contrast,
cells cultured in IL-31SCF1IL-41IL-10 were 63.3% ap-
optotic. These data were similar to those obtained using
IL-3 alone: in both cases, costimulation with IL-4 and IL-
10 induces apoptosis of cultured mast cells even when sur-
vival factors such as IL-3 or SCF are present.
IL-4 and IL-10 Induce Apoptosis in Freshly Isolated Perito-
neal Mast Cells. Although BMMCs are a well-studied as-
say system, we wished to determine if cytokine-induced
apoptosis could also be observed in mature mast cells stim-
ulated ex vivo. Peritoneal mast cells were purified from
eight C57BL/6 3 129 mice by Percoll gradient centrifuga-
tion. These mature mast cells can be maintained in culture
if stimulated with IL-3. To assess apoptosis induced by IL-4
and IL-10, peritoneal mast cells were cultured in a manner
identical to the BMMC assay system, and stained with PI.
As shown in Fig. 3, peritoneal mast cells cultured in IL-
31IL-4 or in IL-31IL-41IL-10 demonstrated a significant
increase in apoptosis compared with cells cultured in IL-3
alone. The total number of cells (viable plus apoptotic, ob-
tained by timed flow cytometer assessment) in each of these
culture conditions was remarkably similar, with a mini-
mum of 3, 694 (6 154) observed with cells cultured in IL-
31IL-41IL-10, and a maximum of 4,719 (6 22) observed
with cells cultured in IL-3 alone. These data corroborate
our results presented in Figs. 1 and 2, and further support
our theory that costimulation with IL-41IL-10 leads to
apoptosis that limits mast cell expansion.
Fas and FasL Expression in BMMCs Treated with IL-4 and
IL-10. Since mast cells have been reported to express the
apoptotic signaling protein Fas (11), we investigated its role
in IL-4– and IL-10–induced apoptosis. Fas surface ex-
pression on BMMCs cultured for 3 d with IL-31IL-4 or
with IL-31IL-10 was not significantly different than cells
treated with IL-3 alone (data not shown). However, when
BMMCs were cultured in IL-31IL-41IL-10, Fas expres-
sion increased by .80% (Fig. 4 A). RPA analysis rein-
forced these data, showing increased mRNA encoding Fas
after 3 d of culture with IL-31IL-41IL-10 compared with
IL-3–treated cells (data not shown).
Induction of apoptosis through the Fas receptor requires
cross-linking by FasL (12), which can be made by BMMCs
(13). We assessed the effect of IL-41IL-10 stimulation on
FasL surface expression on BMMCs. Unlike Fas expres-
sion, BMMCs cultured in IL-31IL-41IL-10 did not ex-
hibit detectable FasL staining (Fig. 4 B).
Figure 3. Stimulation with IL-41IL-10 induces apoptosis in freshly
isolated peritoneal mast cells. Peritoneal mast cells were cultured for 6 d
in the indicated cytokines, and assessed for apoptosis by PI staining. Data
shown represent the mean percent apoptotic cells of triplicate samples
from one of two representative experiments. *P , 0.05.
Figure 2. IL-4 and IL-10 induce apoptosis in BMMCs cultured in IL-3
and SCF. Cells were stimulated for 6 d and assessed by PI staining. Re-
sulting means and standard errors are from three experiments using four
different BMMC populations. *P , 0.05.1097 Yeatman et al.
The lack of FasL staining indicated that cell contact–
mediated Fas killing was an unlikely explanation for the ob-
served BMMC apoptosis. However, FasL is also produced
as a soluble protein (12). To further investigate the role of
Fas/FasL in IL-41IL-10–induced apoptosis, we cultured
BMMCs from lpr (Fas-deficient) and gld (FasL-deficient)
mice and treated them in IL-3 alone or in IL-3 with IL-4
and/or IL-10. As illustrated in Fig. 4 C, culture in IL-
31IL-41IL-10 induced apoptosis in BMMCs derived
from  lpr (25.6 6 3.7%), gld (37.3 6 4.0%), and wild-type
(27.0 6 1.9%) mice at comparable levels (P . 0.05). These
data indicated that neither Fas nor FasL expression was re-
quired for apoptosis induction.
IL-4 and IL-10 Sensitize BMMCs to Fas-mediated
Death. Although Fas expression was not required for the
observed cytokine-induced apoptosis, the upregulation of
Fas expression by culture in IL-31IL-41IL-10 led us to
question if Fas signaling is altered by the culture condi-
tions. To assess Fas-mediated BMMC apoptosis, BMMCs
were cultured in IL-3 alone or in IL-3 plus IL-4 and/or
IL-10 for 3 d before the addition of anti-Fas antibody.
Cells were then cultured for an additional 3 d and assessed
for apoptosis by PI staining. As shown in Fig. 5, Fas cross-
linkage had no effect on survival of BMMCs cultured
in IL-3 alone. However, culture in IL-31IL-4, or in
IL-31IL-41IL-10 greatly increased the sensitivity of
BMMCs to Fas-mediated apoptosis. Thus, functional acti-
vation of Fas was altered by the presence of IL-4 or IL-
41IL-10. The ability of IL-4 to increase Fas-mediated
death without altering Fas expression levels indicated that
upregulation of Fas expression was not strictly required for
this effect.
Surface IgE Cross-Linkage Enhances Apoptosis Induced by
IL-4 and IL-10. Mast cell activation via IgE receptor sig-
naling is a hallmark of allergic disease. Since this activation
results in endogenous cytokine production that might alter
our observed signaling by IL-4 and IL-10, we assessed
BMMC apoptosis after cross-linkage of surface-bound IgE.
BMMCs were allowed to bind IgE, then were washed, and
Figure 4. IL-4 and IL-10 upregulate expression of Fas, but not FasL. (A) BMMCs were cul-
tured in IL-3 alone or in IL-31IL-4 and/or IL-10 for 3 d, then stained for Fas expression. Cells
treated with IL-3 and stained with hamster IgG served as control. For clarity, histograms for
BMMCs treated with IL-3 and IL-4 or with IL-3 and IL-10 are omitted; no significant change
in Fas expression occurred in these conditions. Data shown are representative of three indepen-
dent experiments using four BMMC populations. (B) BMMCs were cultured as described
above in A, and stained for FasL expression. Histograms for BMMCs treated with IL-3 and IL-4
or with IL-3 and IL-10 are omitted for clarity; FasL expression for BMMCs cultured in these
cytokines are no different than for cells treated with IL-3 alone. Data shown are representative
of three independent experiments using four BMMC populations. (C) BMMCs from lpr and gld
mice were cultured in IL-3 or in IL-3 with IL-4 and/or IL-10 for 6 d, and assessed for apoptosis
by PI staining. Data are means and standard errors from four experiments. *P , 0.05, compar-
ing BMMCs cultured in IL-31IL-41IL-10 to the same BMMC population cultured in IL-3
alone. WT, wild-type.
Figure 5. IL-4 and IL-10 sensitize BMMCs to Fas-mediated apoptosis.
BMMCs were cultured in the indicated cytokines for 3 d, after which
anti-Fas antibody was added to a final concentration of 20 mg/ml. Apop-
tosis was assessed by PI staining on day 6. Data shown are representative
of three independent experiments using five BMMC populations. *P ,
0.05, comparing BMMCs cultured with anti-Fas to cells cultured with-
out anti-Fas.1098 Th2 Cytokines Induce Mast Cell Apoptosis
bound IgE was cross-linked with rat anti–mouse IgE, fol-
lowed by goat anti–rat IgG. After 5 h of stimulation,
BMMCs were cultured in IL-3 alone or in IL-3 plus IL-4
and/or IL-10 for 6 d, followed by PI staining. Control cul-
tures received no IgE cross-linkage. A subset of activated cells
was fixed and stained for intracellular expression of TNF-a
to confirm IgE receptor signaling (data not shown).
Surprisingly, IgE cross-linkage alone was sufficient to
induce apoptosis in z25% of cells (Fig. 6), a result not
previously reported. The extent of apoptosis was increased
when BMMCs were activated by IgE cross-linkage and
cultured in IL-31IL-10 or in IL-31IL-41IL-10. On
average, 87% apoptosis was noted in cultures containing
IL-31IL-41IL-10. Similar data were obtained when
BMMCs were activated with plate-bound IgE (data not
shown). These data indicate that FceRI-mediated mast cell
activation, commonplace in allergic disease, may induce
apoptosis and greatly enhances apoptotic signaling by IL-
41IL-10.
IL-4 and IL-10 Decrease mRNA and Protein Levels of bcl-2
and bcl-xL. bcl-2 and bcl-xL have been shown to inhibit
apoptosis (14). Therefore, changes in expression of either
of these proteins might contribute to our observed apopto-
sis. We investigated the effects of IL-4 and IL-10 on
mRNA and protein levels of these proteins, using RPA
and Western blot analysis. As shown in Fig. 7 A, levels of
bcl-2 and bcl-xL mRNA expression were lower in BMMCs
cultured in IL-31IL-41IL-10 than cells treated with IL-3
alone. Costimulation with IL-4 and IL-10 was not required
to decrease bcl-2 and bcl-xL expression, as BMMCs cultured
in IL-31IL-4 or IL-31IL-10 also showed diminished lev-
els of mRNA for these proteins. Western blot analysis cor-
roborated these results (Fig. 7 B): bcl-2 and bcl-xL protein
levels were decreased in BMMCs after culture in IL-3 with
IL-4 and/or IL-10, with an almost total absence of detect-
able protein in cells cultured in IL-31IL-41IL-10.
IL-4 and IL-10 Do Not Induce Apoptosis in BMMCs De-
rived from Stat6 Knockout Mice. The IL-4 receptor signals
through multiple pathways (for a review, see reference 15),
of which Stat6 has been argued to be one of the most criti-
cal. To assess a role for Stat6 in our observed apoptosis sys-
tem, BMMCs derived from Stat6-deficient mice were cul-
tured in IL-3 alone or in IL-3 with IL-4 and/or IL-10,
and assessed for apoptosis by PI staining. Stat6-deficient
BMMCs were completely resistant to apoptosis induced by
IL-31IL-41IL-10, as shown in Fig. 8. These data indicate
that expression of Stat6 is absolutely required for the induc-
tion of apoptosis by IL-31IL-41IL-10. The role of Stat6
in this process remains to be determined and is a central
part of our current investigations.
IL-4 and IL-10 Fail to Induce Apoptosis in Factor-indepen-
dent Mast Cell Lines. Both BMMCs and peritoneal mast
cells are factor-dependent, primary cell populations. How-
ever, many mast cell studies employ factor-independent
mast cell lines, some of which are mastocytoma tumors. To
study the effect of IL-4 and IL-10 on these cell lines, we
stimulated five different factor-independent mast cell lines
with IL-31IL-41IL-10 for 6 d. Fig. 9 is a sample histo-
gram of PI staining data for the P815 factor-independent
Figure 6. IgE cross-linkage induces BMMC apoptosis and enhances
Th2 cytokine–mediated apoptosis. BMMCs were unstimulated or acti-
vated by IgE cross-linkage as described in Materials and Methods, fol-
lowed by culture in the indicated cytokines for 6 d. Apoptosis was as-
sessed by PI staining. Data shown are means and standard errors of three
samples from one of three representative experiments. *P , 0.05, com-
paring BMMCs cultured with IgE cross-linkage to cells cultured without
IgE cross-linkage.
Figure 7. IL-4 and IL-10 decrease mRNA and
protein levels of bcl-2 and bcl-xL. (A) For RPA
analysis, BMMCs were cultured for 6 d in IL-3
alone or IL-3 plus IL-4, IL-10, or both IL-4 and
IL-10. mRNA for the housekeeping genes L32
and glyceraldehyde 3-phosphate dehydrogenase
(GADPH) serve as loading controls. For BMMCs
treated in IL-31IL-41IL-10, mRNA levels de-
creased by 76% for bcl-2 and 71% for bcl-xL com-
pared with mRNA levels for BMMCs cultured in
IL-3 alone. (B) Western blot analysis of bcl-2 and
bcl-xL protein expression in total cell lysates from
BMMCs cultured in IL-3 alone or IL-3 plus IL-4
and/or IL-10 for 6 d. Molecular masses are shown
in parentheses. Data shown in both A and B are
from one of two independent experiments using
three BMMC populations.1099 Yeatman et al.
mast cell line. P815 cells treated with IL-31IL-41IL-10,
with IL-3 alone, or with no cytokines had similar fluores-
cent staining patterns. Mean percentage levels of apoptosis
for P815 cells as well as for the MMC 14, MMC 34,
BMDMC-B, and CFTL-12 factor-independent mast cell
lines treated with IL-4 and IL-10 are shown in Table I.
These data were very similar to those observed with P815
cells: IL-31IL-41IL-10 failed to induce apoptosis after 6 d
in any of these cell lines. It appears that Th2 cytokine-
induced apoptosis is lost in these transformed, factor-inde-
pendent cells.
Discussion
Although IL-4 and IL-10 have each been reported to influ-
ence apoptosis of myeloid cells (16–22), conflicting data
exist in the mast cell field. IL-4 and IL-10 have been dem-
onstrated to promote mast cell survival, development, and
proliferation (3–7). Accordingly, we observed an increase
in BMMC numbers after culture in IL-31IL-41IL-10.
However, by day 3 of these cultures we detected surface
phosphatidylserine expression, an event characteristic of
early apoptosis (10, 23). Increased numbers of pyknotic
cells were observed by day 5, and DNA fragmentation was
detected by day 6.
Induction of apoptosis by IL-4 and IL-10 was not ob-
served solely with BMMCs, since freshly isolated peritoneal
mast cells, cultured ex vivo as pure populations, yielded
similar data. The ability of IL-4 to induce peritoneal mast
cell apoptosis without IL-10 costimulation was an unex-
pected finding that may be specific to the phenotype of
mast cells used. Peritoneal mast cells are a fully mature mast
cell, whereas BMMC cultures have been argued to be in-
completely differentiated. The importance of this finding
remains to be determined, but the role of Th2 cytokines in
mast cell apoptosis appears to be consistent regardless of
these phenotypic nuances. Further, Oskeritzian et al. (24)
recently reported that IL-4 can directly induce apoptosis of
purified human mast cells. Thus, IL-4–mediated regulation
of mast cell survival does not appear to be isolated to our
assay system.
It should be stated clearly that BMMC apoptosis induced
by IL-31IL-41IL-10 was not due to exhaustion of me-
dium components. BMMCs were maintained at low con-
centrations, medium was replenished every 4 d, and cyto-
kines were present in concentrations sufficient to support
proliferation. Furthermore, BMMCs stimulated with IL-3
and SCF for 6 d proliferated to an equal or greater extent
than BMMCs cultured in IL-31IL-41IL-10, but showed
less apoptosis than cells treated with IL-3 alone.
Despite the lack of a Fas requirement for apoptosis in-
duced by IL-31IL-41IL-10, Fas function was greatly en-
hanced in these cultures. Although Fas cross-linkage had
no effect on the viability of BMMCs cultured in IL-3
alone, there was a dramatic increase in Fas-mediated apop-
tosis (.90% apoptotic cells in several experiments) after
culture with IL-31IL-4 or with IL-31IL-41IL-10. As
mast cells would likely be exposed to a FasL-bearing popu-
lation in vivo, our data offer a mechanism by which Th2
cytokines may “prime” mast cells for apoptosis. Given that
BMMCs cultured in IL-31IL-4 showed significant Fas-
induced apoptosis exclusive of changes in Fas expression,
Figure 8. IL-4 and IL-10 do not induce apoptosis in Stat6-deficient
mast cells. BMMCs from Stat6-deficient mice were cultured in the indi-
cated cytokines, and assessed for apoptosis after 6 d of culture. Apoptosis
in BMMCs from Stat6-deficient mice treated with IL-31IL-41IL-10
was not significantly greater than for Stat6-deficient cells cultured in IL-3
alone (P . 0.05). Results shown are means and standard errors from 14
experiments using 7 Stat6-deficient BMMC populations. WT, wild-type.
Figure 9. Factor-independent mast cells fail to undergo apoptosis when
cultured in IL-31IL-41IL-10. P815 mastocytoma cells (A) or wild-type
BMMCs (B) were cultured in the absence of cytokines, with IL-3 alone,
or with IL-31IL-41IL-10 for 6 d. Apoptosis was determined by PI stain-
ing. Data shown are representative of three independent experiments that
gave similar results.1100 Th2 Cytokines Induce Mast Cell Apoptosis
changes in Fas signaling rather than expression may explain
our observations. In support of this, initial experiments
have demonstrated an increase in Fas-associated death do-
main (FADD) mRNA after IL-4 stimulation of BMMCs
(data not shown). Thus, it is possible that IL-4 may alter
the “quality” of the Fas signal, sensitizing mast cells to Fas-
mediated apoptosis.
Mast cells are frequently activated by cross-linkage of
IgE bound to FceRI. This results in the activation of nu-
merous signaling pathways, which might alter apoptotic
signals conveyed by IL-41IL-10. Thus, our theory that
Th2 cytokines such as IL-4 and IL-10 serve as feedback
factors limiting mast cell growth and activation must ac-
count for cell activation status. To this end, we show that
mast cells activated by surface IgE cross-linkage undergo
limited (25%) apoptosis in a 6-d culture. This is the first re-
port of which we are aware that implicates FceRI signaling
in mast cell apoptosis. More impressive was the finding that
nearly 90% of BMMCs activated by IgE cross-linkage be-
fore stimulation with IL-41IL-10 undergo apoptosis.
These findings are analogous to our Fas data, where one
signal “primes” mast cells for apoptotic signaling by a sec-
Table I. IL-41IL-1–induced Apoptosis in Mastocytoma Cell Lines: Data Shown Are Percentage of Apoptotic Cells
Culture conditions
Cell line None IL-3 IL-31IL-4 IL-31IL-10 IL-31IL-41IL-10
MMC 14 15.9 6 1.7 19.4 6 4.8 18.6 6 3.3 16.9 6 3.2 22.9 6 4.2
MMC 34 20.4 6 3.0 18.7 6 2.9 21.4 6 3.7 21.2 6 4.6 19.1 6 3.3
P815 21.6 6 2.8 18.5 6 2.3 17.1 6 3.4 19.4 6 2.2 19.8 6 3.4
BMDMC-B 17.1 6 5.3 17.1 6 1.4 14.8 6 2.0 17.3 6 3.0 16.7 6 4.0
CFTL-12 25.2 6 6.3 20.7 6 4.9 21.3 6 5.0 22.2 6 6.0 22.2 6 4.7
Cells were cultured in the indicated cytokines for 6 d, followed by assessment of apoptosis by PI staining, as detailed in Materials and Methods. Data
shown are mean 6 SE from three independent experiments.
Figure 10. Model of Th2 cytokine–mediated homeostasis in mast cell inflammatory responses. Initial production of IL-4 and IL-10 elicits IgE synthesis
and mast cell proliferation. IgE–antigen interactions activate mast cells, causing production of inflammatory mediators, with the resulting sequelae noted
in allergic disease. This process may be reversed after 3 d, when IL-4 and IL-10 inhibit FceRI and Kit function, and ultimately induce apoptosis of both
mature mast cells and mast cell precursors. The result is a balance of pro- and antiinflammatory reactions, yielding time-limited mast cell hyperplasia and
inflammatory reactions coordinated by the Th2 cytokines IL-4 and IL-10.1101 Yeatman et al.
ond stimulus. Importantly, both Fas and FceRI signaling
are likely to occur in mast cells in vivo, especially during an
inflammatory response. As such, the death of nearly all mast
cells exposed to dual signaling by Th2 cytokines with ei-
ther Fas or FceRI may be a clinically relevant means of
limiting mast cell hyperplasia.
Stimulation with IL-4 and/or IL-10 led to decreased
mRNA and protein levels of bcl-2 and bcl-xL after 6 d in
culture. Similar to our observations of increased Fas-medi-
ated cell killing after IL-4 signaling, combined stimulation
with IL-4 and IL-10 was not necessary to reduce bcl-2 and
bcl-xL expression. These proteins have been shown to
block the effects of the Fas-induced apoptotic pathway (25,
26); thus, their absence may contribute not only to the ob-
served cytokine-induced apoptosis in BMMCs but also to
the ability of these cytokines to prime BMMCs for Fas-
mediated death. This question is the focus of current study.
The mechanism of apoptosis induced by culture in IL-
31IL-41IL-10 remains to be clarified. However, use of
Stat6-deficient BMMCs indicates that expression of this
transcription factor is strictly required. This observation fits
well with our existing theory of IL-4–mediated regulation
of mast cell function. Although IL-4 is known to promote
mast cell survival and proliferation in short-term cultures
(4, 5), we find that longer stimulation (.3 d) leads to di-
minished expression and function of the key signal trans-
duction proteins FceRI and Kit (8, 9). As with apoptosis,
IL-4–mediated regulation of FceRI and Kit requires Stat6
expression. Thus, after 3 d of stimulation with Th2 cyto-
kines, mast cells appear to receive several downregulatory
signals leading to their inactivation and death. All of these
signals require Stat6 expression.
Under normal conditions, mast cell hyperplasia during a
Th2 response is time limited. For example, Nippostrongylus
brasiliensis infection of rats induces a strong Th2 response
with profound intestinal mastocytosis. This mast cell ex-
pansion peaks at day 16 after infection, and resolves after
z5 wk (27). Th2-mediated diseases such as allergic asthma
are frequently associated with eosinophilia, but true masto-
cytosis is not usually noted (for example, see references 28,
29). Thus, Th2 cytokines may be initial stimulators of mast
cell proliferation, but long-term exposure does not appear
to lead to chronic in vivo mastocytosis. It is interesting to
note that Stat6-deficient mice have a greatly exacerbated
mast cell hyperplasia during intestinal nematode infection
or after IL-4 treatment (30). Also, recent reports indicate
that IL-4–deficient mice have a twofold increase in perito-
neal mast cell numbers (31). It is tempting to speculate that
the defect in both strains of mice is related to a failure of
normal apoptotic controls that require IL-4 receptor–medi-
ated Stat6 activation.
Mast cell hyperplasia leading to neoplastic growth is
noted in a collection of diseases that begin with limited
clonal mast cell expansion and progress to systemic masto-
cytosis. This progression from a focal mastocytoma to sys-
temic mastocytosis is associated with aberrant Kit signaling,
thought to lead to unlimited mast cell proliferation (32,
33). In an attempt to mimic this scenario, we investigated
the effect of IL-4 and IL-10 on factor-independent mast
cell lines, some of which are known to bear c-kit mutations
homologous to those found in human mastocytosis (34).
Our studies found that no combination of IL-3, IL-4, or
IL-10 had any effect on apoptosis of these mast cell lines.
If the lack of apoptosis in factor-independent mast cell
lines could be attributed to constitutive Kit signaling, these
data would appear to directly contradict the SCF-aug-
mented apoptosis shown in Fig. 2. Some key points may
explain the different data obtained with primary versus
transformed cell populations. First, primary mast cells re-
spond to Kit in a ligand-dependent manner that is limited
by downregulation of Kit after SCF binding. Constitutively
active forms of Kit in mastocytomas have neither constraint
placed on them. The result may yield both a quantitative
and qualitative difference in signaling, with chronic Kit ac-
tivation circumventing the very death that is enhanced by
limited Kit signaling. In support of this theory, Piao and
colleagues demonstrated that a constitutively active form of
Kit underwent autophosphorylation at different sites than
wild-type Kit, and led to altered substrate activation (35).
Second, other mutations might explain the lack of apopto-
sis observed with factor-independent mast cells. At present,
we find that these lines have reduced expression of IL-4Ra
and constitutive activation of several DNA binding pro-
teins (our unpublished observations). It appears that analyz-
ing the role of mutant Kit receptors may require a cell
transfection system to limit the inherent variability encoun-
tered with spontaneously transformed cell lines. How
SCF–Kit interactions interplay with Th2 cytokines is an
important issue worthy of further study.
Although not addressed by our findings, other Th2 cy-
tokines may function in positively or negatively regulating
mast cell apoptosis. IL-5 and IL-6 have been reported to
support human mast cell survival (29). While IL-13 bears
many similarities to IL-4 and is produced by mast cells (36),
we have been unable to show IL-13–mediated regulation
of FceRI or Kit (Ryan, J.J., unpublished findings). Thus,
the role of Th2 cytokines other than IL-4 and IL-10 in
eliciting mast cell apoptosis is unknown. Clarifying this is-
sue may offer insight into the interplay of cytokine net-
works and their regulation of allergic disease.
The current data, coupled with those we have recently
reported (8, 9), offer a view of Th2 cytokines that includes
not only their initiating allergic inflammation, but also con-
trolling it. This homeostatic role of Th2 cytokines is sum-
marized in Fig. 10. Initially eliciting mast cell proliferation
and IgE synthesis, Th2 cytokine signaling is largely proin-
flammatory. However, continued stimulation for 3 d or
longer inhibits expression and function of the proinflam-
matory/prosurvival mast cell receptors FceRI and Kit.
Subsequently, IL-4 and IL-10 directly induce mast cell ap-
optosis and facilitate Fas-mediated killing. We have re-
cently found these cytokines to also be potent inhibitors of
mast cell development from bone marrow progenitors (our
unpublished findings), a result augmenting the downregu-
latory role of Th2 cytokines. The resulting effect of these
Th2 cytokines is control of mast cell function throughout1102 Th2 Cytokines Induce Mast Cell Apoptosis
the course of an inflammatory response. The actions of
IL-4 and IL-10 on mast cells are characterized by an initial
increase in proliferation and mediator production followed
by a self-limiting resolution of inflammatory activity. This
homeostatic mechanism may explain the absence of chronic
mast cell hyperplasia in some allergic diseases. The loss
of such controls could contribute to neoplastic transforma-
tion.
The authors would like to thank Hey Jin Chong and Marlena Cain
for their help with experiments, Don Purkall and Dr. Shaun Ruddy
for the generous use of their flow cytometry facilities, and John
Myers for his technical assistance. We would also like to thank Dr.
Thomas Huff for many useful conversations, and Dr. William Paul
for his assistance with this manuscript.
This work was supported in part by generous grants from the
American Cancer Society (IN-105, to J.J. Ryan), the Thomas F.
Jeffress and Kate Miller Jeffress Memorial Trust (J-457, to J.J.
Ryan), and National Institutes of Health grant 1R01-AI43433 (to
J.J. Ryan).
Submitted: 8 June 1999
Revised: 7 July 2000
Accepted: 10 August 2000
References
1. Schwartz, L.B., and T.F. Huff. 1993. Biology of mast cells
and basophils. In Allergy: Principles and Practice. E. Middle-
ton, C.E. Reed, E.F. Ellis, N.F. Adkinson, J.W. Yunginger,
and W.W. Busse, editors. Mosby Co., St. Louis. 135–168.
2. Sutton, B.J., and H.J. Gould. 1993. The human IgE network.
Nature. 366:421–428.
3. Paul, W.E. 1991. Interleukin-4: a prototypic immunoregula-
tory lymphokine. Blood. 77:1859–1870.
4. Mosmann, T.R., M.W. Bond, R.L. Coffman, J. Ohara, and
W.E. Paul. 1986. T-cell and mast cell lines respond to B-cell
stimulatory factor 1. Proc. Natl. Acad. Sci. USA. 15:5654–
5658.
5. Hamaguchi, Y., Y. Kanakura, J. Fujita, S.I. Takeda, T. Na-
kano, S. Tarui, T. Honjo, and Y. Kitamura. 1987. Interleu-
kin-4 is an essential factor for in vitro clonal growth of mu-
rine connective tissue mast cells. J. Exp. Med. 165:268–273.
6. Thompson-Snipes, L., V. Dhar, M.W. Bond, T.R. Mos-
mann, K.W. Moore, and D.M. Rennick. 1991. Interleukin
10: a novel stimulatory factor for mast cells and their progen-
itors. J. Exp. Med. 173:507–510.
7. Rennick, D.M., B. Hunte, G. Holland, and L. Thompson-
Snipes. 1995. Cofactors are essential for stem cell factor-depen-
dent growth and maturation of mast cell progenitors: compara-
tive effects of interleukin-3 (IL-3), IL-4, IL-10, and fibroblasts.
Blood. 85:57–65.
8. Ryan, J.J., S. Desimone, G. Klisch, L. McReynolds, K. Han,
R. Kovacs, P. Mirmonsef, and T.F. Huff. 1998. IL-4 inhibits
mouse mast cell FceRI expression through a STAT6-depen-
dent mechanism. J. Immunol. 161:6915–6923.
9. Mirmonsef, P., C.P. Shelburne, C.F. Yeatman II, H.J.
Chong, and J.J. Ryan. 1999. Inhibition of Kit expression by
IL-4 and IL-10 in murine mast cells: role of STAT6 and
phosphatidylinositol 39-kinase. J. Immunol. 163:2530–2539.
10. Koopman, G., C.P.M. Reutelingsperger, G.A.M. Kuijten,
R.M.J. Keehen, S.T. Pals, and M.H.J. van Oers. 1994. An-
nexin V for flow cytometric detection of phosphatidylserine
expression on B cells undergoing apoptosis. Blood. 84:1415–
1420.
11. Hartmann, K., A.L. Wagelie-Steffen, E. von Stebut, and
D.D. Metcalfe. 1997. Fas (CD95, APO-1) antigen expression
and function in murine mast cells. J. Immunol. 159:4006–
4014.
12. Peter, M.E., and P.H. Krammer. 1998. Mechanisms of
CD95 (APO-1/Fas)-mediated apoptosis. Curr. Opin. Immu-
nol. 10:545–551.
13. Wagelie-Steffen, A.L., K. Hartmann, H. Vliagoftis, and D.D.
Metcalfe. 1998. Fas ligand (FasL, CD95L, APO-1L) expres-
sion in murine mast cells. Immunology. 94:569–574.
14. Adams, J.M., and S. Cory. 1998. The Bcl-2 protein family:
arbiters of cell survival. Science. 281:1322–1326.
15. Nelms, K., A.D. Keegan, J. Zamorano, J.J. Ryan, and W.E.
Paul. 1999. The IL-4 receptor: signaling mechanisms and bi-
ological functions. Annu. Rev. Immunol. 17:701–738.
16. Mangan, D.F., B. Robertson, and S.M. Wahl. 1992. IL-4 en-
hances programmed cell death in stimulated human mono-
cytes. J. Immunol. 148:1812–1816.
17. Manabe, A., E. Coustan-Smith, M. Kumagi, F.G. Behm,
S.C. Raimondi, C.-H. Pui, and D. Campana. 1994. Inter-
leukin-4 induces programmed cell death (apoptosis) in cases
of high-risk acute lymphoblastic leukemia. Blood. 83:1731–
1737.
18. Yamamoto, M., K. Kawabata, K. Fujihashi, J.R. McGhee,
T.E. van Dyke, T.V. Bamberg, T. Hiroi, and H. Kiyono.
1996. Absence of exogenous interleukin-4-induced apoptosis
of gingival macrophages may contribute to chronic inflam-
mation in periodontal diseases. Am. J. Pathol. 148:331–339.
19. Gooch, J.L., A.V. Lee, and D. Yee. 1998. Interleukin-4 in-
hibits growth and induces apoptosis in human breast cancer
cells. Cancer Res. 58:4199–4205.
20. Wedi, B., U. Raap, H. Lewrick, and A. Kapp. 1998. IL-4-
induced apoptosis in peripheral blood eosinophils. J. Allergy
Clin. Immunol. 102:1013–1020.
21. Cox, G. 1996. IL-10 enhances resolution of pulmonary in-
flammation in vivo by promoting apoptosis of neutrophils.
Am. J. Pathol. 271:566–571.
22. Itoh, K., and S. Hirohata. 1995. The role of IL-10 in human
B cell activation, proliferation, and differentiation. J. Immu-
nol. 154:4341–4350.
23. Darzynkiewicz, Z., G. Juan, X. Li, W. Gorczyca, T. Mu-
rakami, and F. Traganos. 1997. Cytometry in cell necrobiol-
ogy: analysis of apoptosis and accidental cell death (necrosis).
Cytometry. 27:1–20.
24. Oskeritzian, C.A., Z. Wang, J.P. Kochan, M. Grimes, Z.
Du, H.-W. Chang, S. Grant, and L.B. Schwartz. 1999. Re-
combinant human (rh)IL-4-mediated apoptosis and rhIL-6-
mediated protection of rh-stem cell factor-dependent human
mast cells derived from cord blood mononuclear cell progen-
itors. J. Immunol. 163:5105–5115.
25. Schneider, T.J., D. Grillot, L.C. Foote, G.E. Nunez, and
T.L. Rothstein. 1997. Bcl-x protects primary B cells against
Fas-mediated apoptosis. J. Immunol. 159:4834–4839.
26. Itoh, N., Y. Tsujimoto, and S. Nagata. 1993. Effect of bcl-2
on Fas antigen-mediated cell death. J. Immunol. 151:621–627.
27. Befus, A.D., and J. Bienenstock. 1979. Immunologically-
mediated intestinal mastocytosis in Nippopstrongylus brasilien-
sis-infected rats. Immunology. 38:95–101.
28. Stampfli, M.R., and M. Jordana. 1998. Eosinophilia in anti-
gen-induced airways inflammation. Can. Respir. J. 5(Suppl.1103 Yeatman et al.
A):31A–35A.
29. Yanagida, M., H. Fukamachi, K. Ohgami, T. Kuwaki, H.
Ishii, H. Uzumaki, K. Amano, T. Tokiwa, H. Mitsui, H.
Saito. 1995. Effects of the T-helper 2-type cytokines, inter-
leukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cul-
tured human mast cells. Blood. 86:3705–3714.
30. Urban, J.E., N. Noben-Trauth, D.D. Donaldson, K.B. Mad-
den, S.C. Morris, M. Collins, and F.D. Finkelman. 1998. IL-
13, IL-4Ra, and STAT6 are required for the expulsion of
the gastrointestinal nematode parasite Nippostrongylus brasilien-
sis. Immunity. 8:255–264.
31. Chen, H.J., N. Lycke, and L. Enerback. 1999. Surface and
gene expression of immunoglobulin E receptors on mast cells
and mast cell numbers in interleukin-4-gene knockout mice.
Immunology. 96:544–550.
32. Garriga, M.M., M.M. Friedman, and D.D. Metcalfe. 1988. A
survey of the number and distribution of mast cells in the
skin of patients with mast cell disorders. J. Allergy Clin. Immu-
nol. 82:425–432.
33. Nagata, H., A.S. Worobec, C. Oh, B.A. Chowdhury, S.
Tannebaum, Y. Suzuki, and D.D. Metcalfe. 1995. Identifica-
tion of a point mutation in the catalytic domain of the pro-
tooncogene c-kit in peripheral blood mononuclear cells of pa-
tients who have mastocytosis with associated hematologic
disorder. Proc. Natl. Acad. Sci. USA. 92:10560–10564.
34. Tsujimura, T., T. Furitsu, M. Morimoto, K. Isozaki, S. No-
mura, Y. Matsuzawa, Y. Kitamura, and Y. Kanakura. 1994.
Ligand-independent activation of c-kit receptor tyrosine ki-
nase in a murine mastocytoma cell line P815 generated by a
point mutation. Blood. 83:2619–2626.
35. Piao, X., R. Paulson, P. van der Geer, T. Pawson, and A.
Bernstein. 1996. Oncogenic mutation in the Kit receptor ty-
rosine kinase alters substrate specificity and induces degrada-
tion of the protein tyrosine phosphatase SHP-1. Proc. Natl.
Acad. Sci. USA. 93:14665–14669.
36. Burd, P., W. Thompson, E. Max, and F. Mills. 1995. Acti-
vated mast cells produce interleukin 13. J. Exp. Med. 181:
1373–1380.